Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Part of paid clinical trials in Green Bay, Wisconsin.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT00138203
- Phase
- PHASE2
- Status
- Completed
Conditions
- Recurrent Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- vorinostat — DRUGGiven PO
- laboratory biomarker analysis — OTHERCorrelative studies
Study Details
This phase II trial is studying how well suberoylanilide hydroxamic acid works in treating patients with stage IIIB, stage IV, or recurrent non-small cell lung cancer. Drugs used in chemotherapy, such as suberoylanilide hydroxamic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Suberoylanilide hydroxamic acid may also stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Key Dates
- Start date
- Jun 30, 2005
- Status verified
- Jan 2018
- Primary completion
- Dec 31, 2008
- Completion
- Dec 31, 2008
Study Design
- Enrollment
- 16 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment (vorinostat)Patients receive oral suberoylanilide hydroxamic acid once daily on days 1-14. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Primary Outcome Measure
Response Per RECIST Criteria [ Time Frame: Time from treatment initiation until the end of treatment. The median number of cycles was 3 (range 1-27) ]
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| St. Vincent Regional Cancer Center CCOP | Green Bay | Wisconsin | 54307-3508 | - |
| Gundersen Lutheran | La Crosse | Wisconsin | 54601 | - |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | - |
| UW Health Oncology - 1 South Park | Madison | Wisconsin | 53715 | - |
| Holy Family Memorial Hospital | Manitowoc | Wisconsin | 54221 | - |
Find similar trials in Green Bay, WI
Related Studies
- A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerPHASE1/PHASE2 · Recruiting · Iovance Biotherapeutics, Inc. · Los Angeles, California
- Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung CancerRecruiting · Barbara Ann Karmanos Cancer Institute · Bay City, Michigan
- Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung CancerRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Patient-centered, Optimal Integration of Survivorship and Palliative CareRecruiting · Massachusetts General Hospital · Boston, Massachusetts